Why the ResMed share price is getting smoked

The ResMed Inc. (ASX:RMD) share price got whacked after its latest quarterly results.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc. (ASX: RMD) share price is down 10% today to follow on from last Friday's 12% fall in another leg down on the back of its weaker-than-expected quarterly profit result delivered last Friday.

The company disappointed the market after revealing quarterly constant currency revenue growth of 9% to US$651.1 million translated into a flat adjusted profit of US$144.5 million and flat earnings per share of US$1.

The lack of bottom line growth combined with a ballooning debt pile and interest expenses have led investors to hit the sell button as the company flagged quarterly interest expenses around US$14 million per quarter higher over the six months ahead.

ResMed has spent around US$1.78 billion (A$2.5 billion) on acquisitions mainly in the popular software-as-a-service (SaaS) space over the last couple of years as its CEO pursues a strategy of making it a leader in cloud-based digitally connected healthcare solutions.

While this is an admirable strategy, SaaS businesses tend to boast lofty valuations thanks to their attractive economics and ResMed is now sporting a stretched balance sheet while its top line is not showing a huge return on investment for the shopping spree.

To be fair ResMed and its CEO have an absolutely superb long-term track record, so the market's short-term impatience in lopping 20% off its value may be a good buying opportunity. Moreover, in sending the shares up 35% prior to last week's result investors probably got carried away to the upside over the past year, just as they can also get carried away to the downside.

ResMed is one of three healthcare stocks on the local market I have regularly recommended to investors over the last 4 years, with the other two being CSL Limited (ASX: CSL) and Cochlear Ltd (ASX: COH). On current valuations I'd happily buy CSL and ResMed, but Cochlear shares still look too expensive to me.

Should you invest $1,000 in Cochlear Limited right now?

Before you buy Cochlear Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Cochlear Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd., CSL Ltd., and ResMed Inc. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Aurizon, Brainchip, Clarity, and Domino's shares tumbling today

These shares are under pressure on Monday. What's going on?

Read more »

A business woman looks unhappy while she flies a red flag at her laptop.
Share Fallers

These were the worst-performing ASX 200 shares in February 2025

These shares were sold off last month. Let's see what happened to them.

Read more »

A woman screams and holds her hands up in frustration.
Share Fallers

Why Brainchip, Endeavour, Star, and Telix shares are sinking today

These shares are ending the week deep in the red. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Appen, IDP Education, Objective Corp, and Siteminder shares are tumbling today

These shares are having a tough time on Thursday. Let's find out why.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Appen, Flight Centre, Fortescue, and Platinum shares are sinking today

These shares are having a tough session on hump day. But why?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Domino's, Johns Lyng, Polynovo, and Praemium shares are dropping today

These shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Block, Guzman Y Gomez, Lovisa, and WiseTech shares are sinking today

These shares are starting the week deep in the red. But why?

Read more »

a man holds his arms out and shrugs his shoulders as if indicating he doesn't know the answer to a question he's been asked.
Share Fallers

Why Guzman Y Gomez, Jumbo, PWR, and REA Group shares are crashing today

These shares are ending the week deep in the red. What's going on?

Read more »